Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MSS Metastatic Colorectal Cancer”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Not applicableNot Yet RecruitingNCT06682247
What this trial is testing

A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Feng Wang 200
Testing effectiveness (Phase 2)WithdrawnNCT07137390
What this trial is testing

A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04208958
What this trial is testing

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerMelanomaGastric Cancer+2 more
Vedanta Biosciences, Inc. 56
Large-scale testing (Phase 3)Not Yet RecruitingNCT06959693
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Sun Yat-sen University 590
Testing effectiveness (Phase 2)Looking for participantsNCT06699836
What this trial is testing

Leronlimab in Combination With TAS-102 + Bevacizumab in Previously Treated Participants With mCRC

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
CytoDyn, Inc. 60
Not applicableActive Not RecruitingNCT06199232
What this trial is testing

Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment

Who this might be right for
Liver Metastasis Colon CancerctDNA GenotypeMSS+1 more
Peking University 47
Testing effectiveness (Phase 2)WithdrawnNCT05730673
What this trial is testing

Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer

Who this might be right for
CCR5Microsatellite StableMetastatic+1 more
CytoDyn, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06206096
What this trial is testing

PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC

Who this might be right for
Colorectal CancerRAS MutationColorectal Neoplasms+1 more
Chinese PLA General Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07405736
What this trial is testing

Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticPeritoneal (Metastatic) CancerPeritoneal Metastasis+2 more
Sun Yat-sen University 124
Testing effectiveness (Phase 2)Ended earlyNCT06834399
What this trial is testing

TATE and KN046 in MCRC

Who this might be right for
Colorectal Cancer with Hepatic Metastases
Zhejiang Raygene Pharmaceuticals Co., Ltd 42
Early research (Phase 1)Ended earlyNCT03176264
What this trial is testing

PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Novartis Pharmaceuticals 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06972498
What this trial is testing

A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets

Who this might be right for
Colorectal Cancer With Liver Metastasis
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 35
Not applicableLooking for participantsNCT06551207
What this trial is testing

Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC

Who this might be right for
Metastatic Colorectal Cancer
Liu Huang 80
Early research (Phase 1)Ended earlyNCT03189030
What this trial is testing

Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Aduro Biotech, Inc. 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07224022
What this trial is testing

Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer

Who this might be right for
Colon Cancer
John Strickler, M.D. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07133750
What this trial is testing

PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
CRC (Colorectal Cancer)
Biotheus Inc. 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT06616259
What this trial is testing

First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study

Who this might be right for
Colorectal Cancer (CRC)CapecitabineCetuximab
Meng Qiu 452
Testing effectiveness (Phase 2)Looking for participantsNCT06685276
What this trial is testing

Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Dai, Guanghai 46
Testing effectiveness (Phase 2)Looking for participantsNCT06764680
What this trial is testing

Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticChemotherapyTargeted Therapy+2 more
Sun Yat-sen University 57
Early research (Phase 1)Ended earlyNCT04108481
What this trial is testing

Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticColon CancerMetastatic Colorectal Cancer+7 more
University of Iowa 5
Load More Results